RIBOCICLIB | RIBOCICLIB | ATC L01XE42
ANTINEOPLASTIC TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR (HR)-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2)-NEGATIVE ADVANCED OR METASTATIC BREAST CANCER KINASE INHIBITOR INHIBITOR OF CYCLIN-DEPENDENT KINASE (CDK) 4 AND 6 | ORAL | Tmax 2.5 HOUR VD 1090 LITER PPB 70 PERCENT Cl 25.5 LITER / HOUR HT 32 HOUR | CDK-4 CDK-6 PDB 5L2T (THE X-RAY CO-CRYSTAL STRUCTURE OF HUMAN CDK6 AND RIBOCICLIB.) LIGAND CODE = 6ZZ (link to the list of PDB complexes) Download experimental 3D coordinates of 6ZZ with added hydrogens | KINASE CDK4_HUMAN INHIBITOR P11802 CDK6_HUMAN INHIBITOR Q00534 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |